CAR-T(CAR-T)细胞疗法在非肿瘤性疾病中的应用
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.
CAR-T(CAR-T)细胞在血液系统恶性肿瘤中的应用推动了这种免疫治疗形式的显著进展。
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Clinicopathological features of primary epidural B-cell lymphoma: a study of 14 cases.
Clinicopathological features of primary epidural B-cell lymphoma: a study of 14 cases.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
原发性硬膜外B细胞淋巴瘤(PEBL)是一种罕见肿瘤,初诊时病变累及硬膜外腔。本研究回顾两家机构15年间确诊病例,以描述PEBL的临床病理特征。共发现14例患者,男女各7例,中位年龄63.5岁(范围21–76岁)。患者最常出现脊髓压迫症状,如肢体感觉异常、疼痛和无力。10例(71%)病变累及胸段或胸腰段。8例(57%)为Lugano I期,6例(43%)为II期。9例(64%)国际预后指数(IPI)评分低或低中危,4例(29%)为高中危或高危。所有患者均接受硬膜外肿块手术切除;组织学检查显示8例为弥漫大B细胞淋巴瘤(DLBCL)、5例为滤泡性淋巴瘤、1例为高级别B细胞淋巴瘤(HGBL)。
免疫组化显示14例均为泛B细胞标志物阳性、CD3阴性。根据Hans算法,7例DLBCL为生发中心B细胞(GCB)免疫表型,1例为非GCB表型。8例接受荧光原位杂交(FISH)检测,其中1例HGBL存在MYC和BCL6重排;4例DLBCL分别有单独BCL2(2例)或BCL6(2例)重排;另1例DLBCL同时有BCL2和BCL6重排。全部14例均接受手术切除,其中12例接受化疗,3例还接受放疗。1例接受自体干细胞移植,随后接受CAR-T 治疗。所有患者均有临床随访,中位随访39.5个月(范围1–123个月)。末次随访时,13例存活且完全缓解,1例HGBL患者在确诊后9个月死亡。
我们认为,PEBL主要发生于老年人,最常累及胸腰段,患者IPI评分通常较低或处于低中危。最常见亚型为GCB免疫表型DLBCL。本队列中多数患者接受化疗,预后较好。
Primary epidural B-cell lymphoma (PEBL) is a rare neoplasm that presents initially with involvement of the epidural space.
This study aimed to characterise the clinicopathological features of PEBL through a retrospective analysis of cases diagnosed at two institutions over a 15-year period. A total of 14 patients were identified, including seven women and seven men, with a median age of 63. 5 years (range 21-76 years). These patients most often presented with symptoms of spinal cord compression, such as extremity paraesthesias, pain, and weakness. The thoracic region or thoracolumbar region was commonly involved in 10 (71%) patients. Eight (57%) patients had Lugano stage I disease, and 6six (43%) had stage II disease. Nine (64%) patients had a low or low-intermediate International Prognostic Index (IPI) score, and four (29%) patients had a high-intermediate or high score. All patients underwent surgical excision of the epidural mass, and histological analysis showed diffuse large B-cell lymphoma (DLBCL) in eight patients, follicular lymphoma in five patients, and high-grade B-cell lymphoma (HGBL) in one patient.
Immunohistochemical analysis showed that all 14 cases were positive for pan B-cell markers and negative for CD3. Using the Hans algorithm, seven DLBCL cases had a germinal centre B-cell (GCB) immunophenotype and one case had a non-GCB immunophenotype. Fluorescence in situ hybridisation (FISH) analysis performed on eight cases showed one case of HGBL with MYC and BCL6 rearrangements, four cases of DLBCL with isolated BCL2 (n=2) or BCL6 (n=2) rearrangements, and one case of DLBCL with BCL2 and BCL6 rearrangements.
All 14 patients were treated with excision, 12 of whom were also treated with chemotherapy; three of these patients also received radiation therapy. One patient was treated with an autologous stem cell transplant and subsequently CAR-T therapy. Clinical follow-up was available for all patients with a median of 39. 5 months (range 1-123 months). At the last follow-up, 13 patients were alive and in complete remission and one patient with HGBL died 9 months after diagnosis.
We conclude that PEBL predominantly arises in older adults and most often affects the thoracolumbar region. Patients usually have a low or low-intermediate IPI score. The most frequent type of lymphoma is DLBCL with a GCB immunophenotype. In this cohort, most patients received chemotherapy and had a favourable prognosis.
MEMBER ACCOUNT
登录成功会直接打开下一页。